Sector: MedicalALEXZA PHARMACEUTICA (NASDAQ: ALXA)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 296 |
Technical : | 62 |
Performance : | 255 |
Overall: | 251 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 295 |
Technical : | 23 |
Performance : | 249 |
Overall: | 230 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 295 |
Technical : | 49 |
Performance : | 252 |
Overall: | 240 |
Number of Stocks: | 305 |
Headlines
- Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
Nov 02, 2009 04:30 PM | ALXA
- Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
Oct 02, 2009 09:30 AM | ALXA
- Alexza to Raise $19.7 Million in Private Placement
Sep 30, 2009 09:38 AM | ALXA, RY
- JMP Securities Healthcare Conference to Be Held in New York
Sep 29, 2009 05:30 PM | ACAD, ALNY, ALTH, ALXA, ANDS, ATHN
- Alexza Appoints Andrew L. Busser to Board of Directors
Sep 25, 2009 10:05 AM | ALXA, DD, IBM, MRK
- Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
Sep 14, 2009 07:30 AM | ALXA
- Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Sep 08, 2009 06:00 PM | ALXA, MS
- Extreme FDA Calendar Trades: 18 Stocks Under $5
Jul 05, 2009 08:59 PM | ACAD, AGEN, ALXA, ARYX, CHTP, CLSN
- Analyst Comments: Alexza Pharma, Joy Global, Kookmin Bank, MEMC Electronic Materials, Home Diagnostics
Sep 04, 2008 02:49 PM | ALXA, HDIX, JOYG, KB, WFR
- Analyst Comments: Alexza Pharma, Abbott Lab, Metabasis, Quicksilver, ASM International
Jun 13, 2008 04:45 PM | ABT, ALXA, AMAT, ASMI, KWK, MBRX
- Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro
Aug 26, 2009 04:10 PM | ALXA
- Alexza Reports 2009 Second Quarter Financial Results and Updates Clinical Pipeline Status
Aug 05, 2009 04:10 PM | ALXA
- Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009
Jul 27, 2009 08:31 PM | ALXA
- Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002
Jun 15, 2009 05:30 PM | ALXA
- Alexza's Corporate Presentation to be Webcast at the Piper Jaffray Fourth Annual Europe Conference
Jun 11, 2009 07:53 PM | ALXA
- Alexza's Corporate Presentation to be Webcast at the Eighth Annual JMP Securities Research Conference
May 11, 2009 06:15 AM | ALXA
- Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
May 07, 2009 04:10 PM | ALXA
- Alexza to Announce 2009 First Quarter Financial Results and Update Its Clinical Pipeline Status on Thursday, May 7, 2009
Apr 30, 2009 04:15 PM | ALXA
- Alexza's Corporate Presentation to be Webcast at the Future Leaders in the Biotech Industry Conference
Mar 23, 2009 04:15 PM | ALXA
- Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
Mar 10, 2009 04:05 PM | ALXA
- Form 4 Simms Michael J For: Oct 30 (10K)
Nov 02, 2009 06:22 PM
- Form 4 Moretti August J For: Oct 30 (10K)
Nov 02, 2009 06:21 PM
- Form 4 KING THOMAS BRAXTON For: Oct 05 (10K)
Oct 06, 2009 06:30 PM
- Form 3 BUSSER ANDREW L For: Sep 23 (10K)
Sep 25, 2009 06:01 PM
- Form 3 KESSEL MARK For: Aug 26 (10K)
Sep 08, 2009 10:41 PM
- Form 4 RINGOLD GORDON For: May 07 (10K)
May 11, 2009 05:49 PM
- Form 4 Read J Leighton For: May 07 (10K)
May 11, 2009 05:47 PM
- Form 4 PAKIANATHAN DEEPIKA For: May 07 (10K)
May 11, 2009 05:47 PM
- Form 4 FRAZIER ALAN D For: May 07 (10K)
May 11, 2009 05:47 PM
- Form 4 Barron Hal For: May 07 (10K)
May 11, 2009 05:45 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ALXA
|
Compare to S&P
|
| YTD |
-32.49 %
|
-41.15 %
|
| 4 Weeks |
-3.60 %
|
-4.63 %
|
| 12 Weeks |
-12.65 %
|
-14.82 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -2,700.00 %
|
|
EPS Growth in Last Year: 34.88 %
|
|
Sales Growth in Last Quarter: 2,181.53 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
